EichorEICHOR
Location: Jeffersonville Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Jeffersonville

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Phase 2 · First Urology, PSC · CG Oncology, Inc. · NCT06567743A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Phase 3 · First Urology · Janssen Research & Development, LLC · NCT06319820Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
Phase 2 · First Urology · Dendreon · NCT06134232A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Phase 2 · Site US10007 · Astellas Pharma Global Development, Inc. · NCT02960022Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome
Phase N/A · University of Louisville Hospital · HELP for NOWS Consortium · NCT07278375MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Advanced Regional Surgery Center, LLC · Stryker Instruments · NCT03072927Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Blad
Phase 2 · First Urology · Tyra Biosciences, Inc · NCT06995677Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Can
Phase 3 · First Urology Research (Jeffersonville) · Ferring Pharmaceuticals · NCT06510374A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate
Phase 3 · Research Site · AstraZeneca · NCT06952803Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma
Phase 2 · First Urology · Tyra Biosciences, Inc · NCT07265947Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Phase 1 · First Urology · ORIC Pharmaceuticals · NCT05413421A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Phase 1 · First Urology · Astellas Pharma Global Development, Inc. · NCT04729114
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.